马姆萨迪加纳囊在失眠障碍中的有效性 - 一项随机对照试验
Niranjan A Kedar1, Basavaraj R Tubaki1, G Krishna Priya1
1Department of Kayachikitsa, Shri BMK Ayurveda Mahavidyalaya, A Constituent Unit of KLE Academy of Higher Education & Research, Belagavi, Karnataka, India.
Journal of Ayurveda and integrative medicine
|November 29, 2024
概括
与Tagara Churna相比,Mamsyadi Ghana 囊显著改善了失眠症状. 这两种阿育吠陀治疗均表现出抗焦虑和抗抑郁作用,具有良好的安全性.
科学领域:
- 综合医学是一个整体的医学.
- 艾尔维达药理学 艾尔维达药理学
- 睡眠医学 睡眠医学
背景情况:
- 失眠症是一种普遍的睡眠障碍.
- 阿育吠陀医学,Mamsyadi Ghana 囊,被评估用于失眠管理.
- 传统印度医学为睡眠障碍提供了潜在的治疗途径.
研究的目的:
- 评估Mamsyadi加纳囊在治疗失眠障碍方面的疗效.
- 为了比较Mamsyadi Ghana 囊与Tagara Churna用于治疗失眠.
- 评估阿育吠陀治疗睡眠障碍的安全性和有效性.
主要方法:
- 一项随机研究涉及50名被诊断患有失眠障碍 (DSM-5) 的成年患者.
- 参与者接受了Mamsyadi Ghana囊 (每天500毫克三次) 或Tagara Churna (每天4g三次) 30天.
- 使用失眠严重程度指数 (ISI),匹兹堡睡眠质量指数 (PSQI),爱普沃思睡眠度量表 (ESS),睡眠日记和抑郁焦虑和压力度量表 (DASS) 来衡量有效性. 安全性通过血液参数进行评估.
主要成果:
- 马姆萨迪加纳囊在ISI和ESS分数 (p=0.01) 中与塔加拉丘尔纳相比显著改善,效果大小很大.
- 这两种治疗都显著改善了ISI,ESS,PSQI,DASS得分,以及组内的睡眠日记变量 (p<0.001).
- 这两项干预都表现出良好的安全性,血清肌素和肝功能测试正常.
结论:
- 与Tagara Churna相比,Mamsyadi Ghana 囊在治疗失眠障碍方面表现出更高的疗效.
- 这两种阿育吠陀干预都具有抗焦虑和抗抑郁的特性.
- 马姆萨迪加纳囊为失眠障碍管理提供了一个有前途的阿育吠陀选择.
相关概念视频
Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79
Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
CNS Depressants: Barbiturates and Benzodiazepines
224
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
224


